Description
Elvitegravir is an antiviral compound that inhibits integrase activity. This compound is clinically used to treat HIV infection.
Product Unit Size | Cost | Quantity | Stock |
---|
Elvitegravir is an antiviral compound that inhibits integrase activity. This compound is clinically used to treat HIV infection.
Cas No. | 697761-98-1 |
---|---|
Purity | ≥98% |
Formula | C23H23ClFNO5 |
Formula Wt. | 447.88 |
IUPAC Name | 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid |
Synonym | GS-9137, JTK-303 |
Solubility | DMSO 89 mg/mL (198.71 mM) Ethanol 35 mg/mL (78.14 mM) Water Insoluble |
Appearance | White to off white powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Reviriego C. Elvitegravir for the treatment of HIV infection. Drugs Today (Barc). 2014 Mar;50(3):209-17. PMID: 24696866.
Shimura K, Kodama E, Sakagami Y, et al. Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol. 2008 Jan;82(2):764-74. PMID: 17977962.
STAT3 inhibitor.
Melatonin analog; MT1/2 agonist.
Mycotoxin produced by Aspergillus; actin polyme...
Long chain acylcarnitine involved in fatty acid...
mTOR inhibitor.
Phenothiazine, FIASMA; D1/2/3/4, 5-HT1/2, M1/2 ...
Endogenous tachykinin peptide, involved in infl...
Mycotoxin metabolite
STING agonist
Phenol found in Zingiber; 5-HT3 antagonist.
Expectorant.
Endogenous hormone neurotransmitter, involved i...
Acyclic nucleotide (adenosine) analog, adefovir...
Anti-diabetic alkaloid
Folate source co-administered with methotrexate...
CRTH2 inhibitor, TxA2 antagonist.
Semi-synthetic avermectin; GABA potentiator.
N-Des-2-methylpropan-2-ol Docetaxel is an impur...
Diterpene antibiotic produced by Cephalosporum;...
Neuromodulator, biomarker